SANTA ANA, Calif., April 07, 2021 (GLOBE NEWSWIRE) -- NKGen Biotech, a biotechnology company harnessing the power of the body's immune system through the development of Natural Killer (NK) cell therapies, today announced that it has appointed Philip Moody as its Chief Financial Officer (CFO). Mr. Moody is a highly accomplished CFO who brings critical financial leadership experience to NKGen Biotech.

Read this article:

NKGen Biotech Announces Appointment of Philip Moody as Chief Financial Officer

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh